|
Evangelos is currently deputy head of the Risk Management Division in the European Central Bank (ECB). Since January 1, 1999, the ECB has been responsible for conducting monetary policy for the Euro area—the world’s largest economy after the United States. The ECB’s primary objective is to maintain the euros' purchasing power and thus price stability in the Euro area. The Risk Management Division in the ECB is responsible for managing the financial risks of the full range of the ECB’s market operations. These tasks include market, credit, and liquidity risk management for the asset management activities of the ECB’s investment portfolios, consisting of about of €50 billion in foreign reserves and gold holdings and about €10 billion in Euro-denominated assets under active management. In addition, the Division manages the risks of the Eurosystem’s credit operations, the operations providing liquidity to the banking system in the Euro area, which amounted to €830 billion at the end of 2008. This task includes the monitoring of the credit assessment and valuation of over €11 trillion of assets eligible to collateralise these operations. This presentation was given on October 10, 2009. View the keynote speech from this event, which was given by Jon Moynihan SM '77.
|
Video Length: 1264
Date Found: March 26, 2010
Date Produced: March 25, 2010
|
|
MIT TechTV |
July 13, 2011
|
MIT TechTV |
July 07, 2011
|
MIT TechTV |
June 27, 2011
The emerging cleantech venture`s pilot has been supported by government grants now it is time to scale. Cleantech requires significant funding, often larger than traditional vc`s are structured to support. How does a cleantech venture scale to grow? Hear from national project developer ...
|
MIT TechTV |
June 27, 2011
Three leading New York venture capital firms will provide their strategies for 2011. Understanding venture capital firms’ strategies is critical in order to obtain venture capital. Prior to the panel discussion, PwC will present a summary of the 3rd quarter 2010 MoneyTree Report. The MoneyTree ...
|
MIT TechTV |
June 27, 2011
With the recent passage of healthcare reform legislation, corporate consolidations, and a `get tough` policy at the FDA, it is difficult to tell what the commercial healthcare landscape will look like during the next five years. A distinguished panel of experts representing biopharmaceuticals, ...
|
|
|
|
|
|
Featured Content
Featuring websites that enhance the internet user’s experience.
|